Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Follicular 2Pulmonary Disease, Chronic Obstructive 1Myasthenia Gravis 1Asthma 1

Interventions

Fluticasone-Salmeterol Drug Combination 3Etanercept 3Fluticasone 2Budesonide 2Beclomethasone 2perflutren 1laninamivir 1fluticasone-formoterol 1Sulfur Hexafluoride 1Prednisolone 1NVP-QAV680 1Lysine Acetyltransferase 5 1Health Information Exchange 1Formoterol Fumarate 1Exercise 1Escitalopram 1CS 8958 1Budesonide, Formoterol Fumarate Drug Combination 1Bronchial Thermoplasty 1Blood Specimen Collection 1Azithromycin 1Amoxicillin-Potassium Clavulanate Combination 1Albuterol 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Asthma × Albuterol × Clear all
NCT02458482 2020-11-13

Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children

Vanderbilt University Medical Center

Phase NA Withdrawn
Lymphoid

Asthma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡